|
OMIM |
Link |
Information gain |
01 |
|
PTH
|
[NCBI]
|
0.0205995
|
|
|
HRPT3
|
[NCBI]
|
0.00266538
|
|
|
HRPT1
|
[NCBI]
|
0.00255622
|
|
|
HHC1
|
[NCBI]
|
0.00210583
|
|
|
HRPT2
|
[NCBI]
|
0.00150947
|
|
|
NSHPT
|
[NCBI]
|
0.00127403
|
|
|
HHC2
|
[NCBI]
|
0.000991404
|
|
|
CASR
|
[NCBI]
|
0.000981977
|
|
|
HHC3
|
[NCBI]
|
0.000938013
|
|
|
MEN1
|
[NCBI]
|
0.000859942
|
|
|
HRPT2
|
[NCBI]
|
0.000365326
|
|
|
VDR
|
[NCBI]
|
0.000244764
|
|
|
RA
|
[NCBI]
|
0.000217093
|
|
|
hypophosphatemic rickets, x-linked dominant
|
[NCBI]
|
0.000214554
|
|
|
parathyroid carcinoma
|
[NCBI]
|
0.000189242
|
|
|
MEN2A
|
[NCBI]
|
0.000177989
|
|
|
hypercalcemia, idiopathic, of infancy
|
[NCBI]
|
0.000152381
|
|
|
SLE
|
[NCBI]
|
0.000151188
|
|
|
EGFR
|
[NCBI]
|
0.000140019
|
|
|
EGF
|
[NCBI]
|
0.000136899
|
|
|
nephropathy, deafness, and hyperparathyroidism
|
[NCBI]
|
0.000110008
|
|
|
hyperparathyroidism, neonatal self-limited primary, with hypercalciuria
|
[NCBI]
|
0.000110008
|
|
|
PRL
|
[NCBI]
|
0.000107019
|
|
|
hyperparathyroidism, primary, caused by water clear cell hyperplasia
|
[NCBI]
|
8.75539e-05
|
|
|
PCNA
|
[NCBI]
|
8.09545e-05
|
|
|
BGLAP
|
[NCBI]
|
8.08828e-05
|
|
|
RTADR
|
[NCBI]
|
6.95222e-05
|
|
|
AHO
|
[NCBI]
|
6.30206e-05
|
|
|
metaphyseal chondrodysplasia, jansen type
|
[NCBI]
|
5.92612e-05
|
|
|
HRD
|
[NCBI]
|
5.5869e-05
|
|
|
KCS
|
[NCBI]
|
5.5869e-05
|
|
|
polycystic kidneys
|
[NCBI]
|
5.29278e-05
|
|
|
C1ORF27
|
[NCBI]
|
5.21505e-05
|
|
|
sen15, yeast, homolog of
|
[NCBI]
|
5.21505e-05
|
|
|
NPL
|
[NCBI]
|
5.21505e-05
|
|
|
EDEM3
|
[NCBI]
|
5.21505e-05
|
|
|
SMG7
|
[NCBI]
|
5.21505e-05
|
|
|
EPO
|
[NCBI]
|
4.8175e-05
|
|
|
BCNS
|
[NCBI]
|
4.67737e-05
|
|
|
PTHLH
|
[NCBI]
|
4.6644e-05
|
|
|
GACI
|
[NCBI]
|
4.37281e-05
|
|
|
acromegaly
|
[NCBI]
|
4.30413e-05
|
|
|
alkaptonuria
|
[NCBI]
|
4.0005e-05
|
|
|
NPHP1
|
[NCBI]
|
3.94642e-05
|
|
|
NMNAT2
|
[NCBI]
|
3.84223e-05
|
|
|
RGS8
|
[NCBI]
|
3.84223e-05
|
|
|
FIH
|
[NCBI]
|
3.61399e-05
|
|
|
LPL
|
[NCBI]
|
3.4772e-05
|
|
|
PCTT
|
[NCBI]
|
3.34233e-05
|
|
|
DM2
|
[NCBI]
|
3.05388e-05
|
|
|
mucolipidosis ii
|
[NCBI]
|
2.96927e-05
|
|
|
prostate cancer
|
[NCBI]
|
2.86375e-05
|
|
|
TG
|
[NCBI]
|
2.81718e-05
|
|
|
G6PD
|
[NCBI]
|
2.6145e-05
|
|
|
FGF23
|
[NCBI]
|
2.33555e-05
|
|
|
TH
|
[NCBI]
|
2.32875e-05
|
|
|
APS1
|
[NCBI]
|
2.04659e-05
|
|
|
IL6R
|
[NCBI]
|
1.85115e-05
|
|
|
MAS
|
[NCBI]
|
1.83108e-05
|
|
|
CYP27B1
|
[NCBI]
|
1.70217e-05
|
|
|
HSCR1
|
[NCBI]
|
1.65817e-05
|
|
|
ACP5
|
[NCBI]
|
1.5306e-05
|
|
|
CMH
|
[NCBI]
|
1.51654e-05
|
|
|
PTHR1
|
[NCBI]
|
1.24145e-05
|
|
|
SDHD
|
[NCBI]
|
1.20346e-05
|
|
|
FHIT
|
[NCBI]
|
9.54164e-06
|
|
|
TNFRSF11B
|
[NCBI]
|
4.04776e-06
|
|
|
GHRH
|
[NCBI]
|
2.38989e-06
|
|
|
GIP
|
[NCBI]
|
1.21922e-06
|
|
|
RET
|
[NCBI]
|
7.61781e-07
|
|
|
ABCC1
|
[NCBI]
|
7.19008e-07
|
|
|
CD
|
[NCBI]
|
5.50108e-07
|
|
|
ADM
|
[NCBI]
|
1.47281e-07
|
|
|
IAPP
|
[NCBI]
|
4.12735e-08
|
|
|
PD
|
[NCBI]
|
1.19023e-08
|
|
|
ALB
|
[NCBI]
|
2.06793e-09
|
|